Dallas、TXにおける大腸癌の臨床試験
Dallasとその周辺地域（約30マイル以内）の拠点で、大腸癌に関する33件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- UT Southwest Simmons Cancer Center, Dallas
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #89, Dallas
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
被験者募集中第1相
- SCRI at Mary Crowley, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
被験者募集中第3相
- Parkland Health and Hospital System, Dallas
- Texas Oncology DFW, Dallas
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
被験者募集中第1相
- GSK Investigational Site, Dallas
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
被験者募集中第1相
- Research Site, Dallas
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
被験者募集中第3相
- Texas Oncology DFW, Dallas
- UT Southwestern, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
被験者募集中第1/2相
- Baylor, Scott and White Research Institute, Dallas
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
被験者募集中第3相
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
被験者募集中第1相
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
被験者募集中第1相
- Texas Oncology - DFW (Sammons CC), Dallas
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
被験者募集中第1相
- NEXT - Dallas, Dallas
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
被験者募集中第3相
- University of Texas Southwestern Medical Center, Dallas
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
被験者募集中第3相
- Clinical Study Site, Dallas
- Clinical Study Site, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
被験者募集中第1/2相
- Texas Oncology, P.A., Dallas
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Mary Crowley Cancer Research, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
被験者募集中第1/2相
- Texas Oncology, Dallas
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
被験者募集中第3相
- Texas Oncology - DFW, Dallas
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
被験者募集中第2相
- Texas Oncology - DFW, Dallas
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
被験者募集中第4相
- University of Texas Southwestern Medical Center, Dallas
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
被験者募集中第1/2相
- University of Texas Southwestern Medical Center, Dallas
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
被験者募集中第1相
- NEXT Texas LLC - Dallas, Dallas
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
被験者募集中第1相
- UT Southwestern Simmons Cancer Center, Dallas
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
被験者募集中第1相
- Sarah Cannon Research Institute at Mary Crowley, Dallas
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
被験者募集中第1相
- Sarah Cannon Research Institute at Mary Crowley, Dallas
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
被験者募集中第1/2相
- Mary Crowley Cancer Research, Dallas
Early-Onset Colorectal Cancer Patients Too Young for Screening
被験者募集中観察研究
- Methodist Dallas Medical Center- Clinical Research Institute, Dallas
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
被験者募集中第2相
- NGM Clinical Study Site, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- NEXT Oncology - Dallas, Dallas
Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.
被験者募集中第1/2相
- NEXT Oncology Dallas, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
被験者募集中第4相
- UT Southwestern Medical Center, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
被験者募集中第1相
- NEXT Dallas, Dallas
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
被験者募集中第1相
- NEXT Oncology, Dallas, Dallas
他の都市における大腸癌の試験
- Houston, TX102件の研究
- New York City, NY78件の研究
- Nashville, TN69件の研究
- Boston, MA63件の研究
- Los Angeles, CA59件の研究
- Arlington, VA52件の研究
- St. Louis, MO50件の研究
- San Antonio, TX46件の研究
- Philadelphia, PA44件の研究
- Grand Rapids, MI40件の研究
- Baldwin Park, CA37件の研究
- Chicago, IL34件の研究
Dallasにおける他の研究
- 乳がん55件の研究
- 非小細胞肺癌52件の研究
- 転移性癌42件の研究
- 心不全42件の研究
- がん（全種類）37件の研究
- 前立腺がん36件の研究
- 肥満症30件の研究
- 卵巣がん28件の研究
- 肺がん27件の研究
- 膀胱癌27件の研究
- 子宮内膜がん24件の研究
- 腎臓がん（腎細胞がん）23件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。